Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORY: Ezetimibe and Simvastatin in Chronic Proteinuric Nephropathy
NCT00861731Phase 4Unknown
- Sponsor
- AOU Sassari
- Start
- Nov 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ezetimibe in chronic kidney disease (CKD) and hypercholesterolemia (3 arms), sponsored by AOU Sassari. Primary endpoint: Proportion of patients achieving optimum lipid control (LDL-cholesterol < 70 mg/dl) at 12 months. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
chronic kidney disease (CKD)hypercholesterolemia
Beyond the preview
Go deeper on NCT00861731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861731.